Achord JL. A prospective randomized clinical trial of peripheral amino acid-glucose supplementation in acute alcoholic hepatitis. Am J Gastroenterol. 1987;82:871–5.

Barbara A. Maher et al. Magnetite pollution particles in the human brain. Proceedings of the National Academy of Sciences Sep 2016, 201605941.

Brandon-Warner E1, Eheim AL, Foureau DM, Walling TL, Schrum LW, McKillop IH. Silibinin (Milk Thistle) potentiates ethanol-dependent hepatocellular carcinoma progression in male mice. Cancer Lett. 2012 Dec 29;326(1):88-95.

Bui Han SH. Alcoholic Hepatitis. Curr Treat Options Gastroenterol. 2001;4:511–6.

Bunout D, Aicardi V, Hirsch S, et al. Nutritional support in hospitalized patients with alcoholic liver disease. Eur J Clin Nutr. 1989;43:615–21.
Cabré E, Rodríguez-Iglesias P, Caballería J, et al. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: A multicenter randomized trial. Hepatology. 2000;32:36–42.

Calvey H, Davis M, Williams R. Controlled trial of nutritional supplementation, with and without branched chain amino acid enrichment, in treatment of acute alcoholic hepatitis. J Hepatol. 1985;1:141–51.

Chatauret N, Desjardins P, Zwingmann C, Rose C, Rao KV, Butterworth RF. Direct molecular and spectroscopic evidence for increased ammonia removal capacity of skeletal muscle in acute liver failure. J Hepatol. 2006;44:1083–8.

Cohen SM, Ahn J. The diagnosis and management of alcoholic hepatitis. Aliment Pharmacol Ther. 2009;30:3–13.

Córdoba J, López-Hellín J, Planas M, et al. Normal protein diet for episodic hepatic encephalopathy: Results of a randomized study. J Hepatol. 2004;41:38–43.

Crinnion WJ. The CDC fourth national report on human exposure to environmental chemicals: what it tells us about our toxic burden and how it assist environmental medicine physicians. Altern Med Rev. 2010 Jul;15(2):101-9.

Dong MH, Saab S. Complications of cirrhosis. Dis Mon. 2008;54:445–56.

Egner PA, Chen JG, Zarth AT, et al. Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: results of a randomized clinical trial in China. Cancer Prev Res (Phila). 2014;7(8):813-823.

Eisele JW, Reay DT. Deaths Related to Coffee Enemas. JAMA. 1980;244(14):1608–1609.
Grant DM. Detoxification pathways in the liver. J Inherit Metab Dis. 1991;14(4):421-30.

Griffith CM, Schenker S. The role of nutritional therapy in alcoholic liver disease. Alcohol Res Health. 2006;29:296–306.

Henkel AS, Buchman AL. Nutritional support in patients with chronic liver disease. Nat Clin Pract Gastroenterol Hepatol. 2006;3:202–9.

Hinson JA, Forkert PG. Phase II enzymes and bioactivation. Can J Physiol Pharmacol. 1995 Oct;73(10):1407-13.

Hirsch S, Bunout D, de la Maza P, et al. Controlled trial on nutrition supplementation in outpatients with symptomatic alcoholic cirrhosis. J Parenter Enteral Nutr. 1993;17:119–24.

IARC (2018). Les cancers attribuables au mode de vie et à l’environnement en France métropolitaine. Lyon: International Agency for Research on Cancer.

Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials. 1996;17:1–12.
Kearns PJ, Young H, Garcia G, et al. Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology. 1992;102:200–5.

Kondrup J, Müller MJ. Energy and protein requirements of patients with chronic liver disease. J Hepatol. 1997;27:239–47.

Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med. 2009;360:2758–69.

M. B. Salem, H. Affes, K. Ksouda et al., “Pharmacological studies of artichoke leaf extract and their health benefits,” Plant Foods for Human Nutrition, vol. 70, no. 4, pp. 441–453, 2015.

Marchesini G, Bianchi G, Merli M, et al. Italian BCAA Study Group Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: A double-blind, randomized trial. Gastroenterology. 2003;124:1792–801.

Mehmetçik G, Ozdemirler G, Koçak-Toker N, et al. (2008). Effect of pretreatment with artichoke extract on carbon tetrachloride-induced liver injury and oxidative stress. Exp Toxicol Pathol 60:475–80

Mendenhall C, Bongiovanni G, Goldberg S, et al. VA Cooperative Study on Alcoholic Hepatitis III: Changes in protein-calorie malnutrition associated with 30 days of hospitalization with and without enteral nutritional therapy. J Parenter Enteral Nutr. 1985;9:590–6.

Mezey E, Caballería J, Mitchell MC, Parés A, Herlong HF, Rodés J. Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: A randomized controlled trial. Hepatology. 1991;14:1090–6.

Morgan TR, Moritz TE, Mendenhall CL, Haas R. Protein consumption and hepatic encephalopathy in alcoholic hepatitis. VA Cooperative Study Group #275. J Am Coll Nutr. 1995;14:152–8.

Muto Y, Sato S, Watanabe A, et al. Long-Term Survival Study Group Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol. 2005;3:705–13.

Nasrallah SM, Galambos JT. Amino acid therapy of alcoholic hepatitis. Lancet. 1980;2:1276–7.

Naveau S, Pelletier G, Poynard T, et al. A randomized clinical trial of supplementary parenteral nutrition in jaundiced alcoholic cirrhotic patients. Hepatology. 1986;6:270–4.

Olivo SA, Macedo LG, Gadotti IC, Fuentes J, Stanton T, Magee DJ. Scales to assess the quality of randomized controlled trials: A systematic review. Phys Ther. 2008;88:156–75.

Patel SS, Beer S, Kearney DL, Phillips G, Carter BA. Green tea extract: a potential cause of acute liver failure. World J Gastroenterol. 2013;19(31):5174-7.

Plauth M, Merli M, Kondrup J, Weimann A, Ferenci P, Müller MJ, ESPEN Consensus Group ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr. 1997;16:43–55.

Rambaldi A, Saconato HH, Christensen E, Thorlund K, Wetterslev J, Gluud C. Systematic review: Glucocorticosteroids for alcoholic hepatitis – a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials. Aliment Pharmacol Ther. 2008;27:1167–78.

Riordan SM, Williams R. Gut flora and hepatic encephalopathy in patients with cirrhosis. N Engl J Med. 2010;362:1140–2.

Rongey C, Kaplowitz N. Current concepts and controversies in the treatment of alcoholic hepatitis. World J Gastroenterol. 2006;12:6909–21.
Rush J.W., S.D.Sandiford (2003) Plasma glutathione peroxidase in healthy young adults: influence of gender and physical activity. Clin.Biochem. 36:345-351.

Schenker S, Halff GA. Nutritional therapy in alcoholic liver disease. Semin Liv Dis. 1993;13:196–209.

Seymour CA. Dietary management of hepatic encephalopathy. Too many myths persist. BMJ. 2000;320:234.

Simon D, Galambos JT. A randomized controlled study of peripheral parenteral nutrition in moderate and severe alcoholic hepatitis. J Hepatol. 1988;7:200–7.

Tome S, Lucey MR. Review Article: Current management of alcoholic liver disease. Aliment Pharmacol Ther. 2004;19:707–14.

Whitfield K, Rambaldi A, Wetterslev J, Gluud C. Pentoxifylline for alcoholic hepatitis. Cochrane Database Syst Rev. 2009;(4):CD007339.

Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373-7.